WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Postmarket & security

THE TAPE

Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register

The Tracker / July 2026 / K261829

510(k) cleared

Profoject Dual-Safety Pen Needles

CMT Health PTE., Ltd. · Jul 29, 2026 · K261829

FDA cleared the Profoject Dual-Safety Pen Needles from CMT Health PTE., Ltd. on Jul 29, 2026 under K261829, a traditional 510(k). The device falls under product code FMI, Needle, Hypodermic, Single Lumen, regulated at 21 CFR 880.5570 as a Class 2 device. The review panel was General Hospital.

FDA logged the submission as received on Jun 2, 2026. The decision came 57 days later, inside the 90 FDA-day goal for a 510(k).

CMT Health PTE., Ltd. has 7 other decisions in the tracker over the last 12 months: K260739 (Profoject Pen Needles (Model A; Model B)), K260514 (Profoject Safety Needle; Profoject Syringe with Safety Needle; Profoject Low Dead Space Syringe with Safety Needle), K260855 (Profoject Safety Pen Needles), K253268 (Profoject Enteral/Oral Feeding Syringe; Profoject Reusable Enteral/Oral Feeding Syringe (Model A, Model B); Profoject ENFit Adaptor; Profoject Enteral Feeding Syringes Cap).

Questions & Answers

What did FDA clear under K261829?

K261829 is the FDA 510(k) for Profoject Dual-Safety Pen Needles, submitted by CMT Health PTE., Ltd.. FDA's decision date was Jul 29, 2026, under product code FMI (Needle, Hypodermic, Single Lumen).

Who makes the Profoject Dual-Safety Pen Needles?

CMT Health PTE., Ltd., based in Singapore, is the applicant of record for K261829.

How long did the K261829 review take?

FDA received the submission on Jun 2, 2026 and issued its decision on Jul 29, 2026, 57 days later.

← All decisions in July 2026